Sign In
Buy ABUS
$4.34
-0.0700 (-1.59%)
At Close: Jul 31, 2026
6 Biotechnology Stocks Moving In Wednesday's Pre-Market Session
12:42pm, Wednesday, 05'th Feb 2020
Gainers
• Moleculin Biotech, Inc. (NASDAQ:MBRX) stock rose 35.2% to $1.19 during Wednesday's pre-market session.
• Arbutus Biopharma, Inc. (NASDAQ:ABUS) shares rose...
Arbutus Biopharma (NASDAQ:ABUS) and GlycoMimetics (NASDAQ:GLYC) Head-To-Head Contrast
06:46am, Friday, 17'th Jan 2020
Arbutus Biopharma (NASDAQ:ABUS) and GlycoMimetics (NASDAQ:GLYC) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of th
The Daily Biotech Pulse: UCB To Buy Ra Pharma, Reata Reacquires Rights To Nrf2 Activators From AbbVie, BioNTech IPO
11:31am, Thursday, 10'th Oct 2019
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 9) Aprea Therapeutics Inc (NASDAQ: APRE ) (IPOed Oct.
